La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Procaps Gr a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Procaps Gr..

Procaps Gr (NASDAQ:PROC) Azioni, Catena delle Opzioni

Procaps Gr

Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.

Procaps Group SA

PROCEPT BioRobotics Corporation - Common Stock

PROCEPT BioRobotics Corp

PROCREDIT HOLDING AG by Procredit Holding Ag

ProCredit Holding AG

Processa Pharmaceuticals, Inc. - Common Stock

Processa Pharmaceuticals Inc

Procore Technologies Inc

Procter & Gamble Company (The) Common Stock

Procter & Gamble Co

Procure ETF Trust II Disaster Recovery Strategy ETF

Procure Space ETF

Procurri Corp Ltd

Procyon Corp

The cryptocurrency market has undergone a remarkable transformation, evolving from a volatile asset favoured by retail traders into a more established space that is increasingly attracting institutional investors. Strengthened market infrastructure and a shifting regulatory environment have encouraged traditional financial institutions to explore the potential of digital assets.
In an exclusive interview with Benzinga, EMURGO's COO Nikhil Joshi talks about the company's blockchain innovation and transformation strategy, how it is handling rapidly changing regulatory environment, challenges faced by the global crypto market and much more.
EMURGO, a global blockchain technology company, is one of the founding entities of the Cardano blockchain. It delivers products and services aimed at advancing the adoption of Cardano's Web3 ecosystem through initiatives in education, investment, and infrastructure development.
How is EMURGO innovating in Web3, and what impact will it have on traditional finance and global financial systems?
As a founding entity of the Cardano network, EMURGO is pioneering Web3 innovations through its suite of products and partnerships aimed at accelerating the commercial adoption of blockchain. Since our inception in 2019, we have developed and advanced solutions in fintech and cemented strategic collaborations to bridge the gap between decentralised technologies and mainstream financial systems. Today, as the tokenisation of real-world assets gains traction and is slated to redefine the traditional financial ecosystem, EMURGO has emerged as a catalyst for Web3 solutions, steering education and adoption for the burgeoning sector.
As advocates for Web3, EMURGO has also been working closely with the public sector to drive positive development for the blockchain industry. Through concerted efforts, we have been embedding trust and transparency with policymakers, forging opportunities that reduce counterparty risks, streamline regulatory compliance, and pave the way for a more inclusive financial ecosystem.
Can you explain how EMURGO&#8217;s collaboration with Huawei Cloud is helping to scale Web3 solutions across the Asia Pacific region and beyond?
Our partnership with Huawei Cloud is a significant milestone for EMURGO and the Cardano ecosystem. As one of the world's largest cloud computing companies, Huawei Cloud&#8217;s entry into the Cardano ecosystem will bring Huawei's cloud infrastructure into Cardano's open-source public blockchain ecosystem, driving growth and Web3 adoption in APAC and Africa. At the same time, the joint partnership will lower the entry barriers for non-native players to utilise Cardano nodes and set up tech infrastructure to easily build solutions on the Cardano network.
What are EMURGO's key strategies for navigating the rapidly changing regulatory environment in Asia, and how will this affect the future of Web3 adoption?
The future of Web3 adoption in Asia hinges on the balance between innovation and regulation. Already, Asia Pacific nations are taking the lead in crypto adoption worldwide, and we've seen how jurisdictions from Singapore to Hong Kong are implementing regulatory clarity to better shape the emerging digital asset sector.
As a member of the Web3 Subcommittee of the Singapore Fintech Association, for example, EMURGO actively supports the mission to create and sustain a responsible and innovative Web3 ecosystem in Singapore and the region. This includes fostering a framework focused on innovation, consumer protection, financial education, and market integrity, which are crucial to guiding sustainable Web3 growth. Seeing the value of both sides of the coin, EMURGO's strategies have been shaped to foster dialogue and compliance within the Web3 sector, encouraging an optimal environment for innovation to thrive.
How does EMURGO integrate Web3 technology within existing Web2 frameworks, and what challenges have been encountered during this transition?
To us at EMURGO, the shift from Web2 to Web3 is not about abandoning the old for the new. Because our company's background is blended, with a few of us coming from more traditional backgrounds, we see value in melding the two worlds to complement both Web2 and Web3 ecosystems. Since our founding, we have been actively pushing for interoperability — creating tools that allow Web2 platforms to communicate better with blockchain networks. This helps traditional companies dip their toes into Web3 by incorporating features like tokenisation or decentralised identity without needing to start from scratch.
Traditional Web2 systems are built to handle millions of transactions quickly, while many newer blockchain networks face a combination of challenges due to its decentralised nature — its consensus mechanisms and the trade-offs it requires to maintain security across its decentralised network. EMURGO's role is essential here, as we invest in and support solutions that drive opportunities to integrate blockchain more efficiently, paving the way for seamless interoperability between Web2 and Web3.
What upcoming initiatives does EMURGO have planned to ensure a strong, sustainable future for the Web3 ecosystem?
Earlier in September EMURGO partnered with Ibex, the corporate innovation arm of Antler, one of the world's most active early-stage investors. The collaboration will leverage EMURGO's deep expertise and Antler's expansive global network to drive innovation at the intersection of fintech and Web3 technologies. This is the first announced partnership in a pipeline of upcoming collaborations that EMURGO will announce in due time that will focus on identifying, investing, and driving the growth of global founders and startup projects across the world.
What are the biggest challenges facing the global crypto market today, and how are these affecting the growth and adoption of blockchain technology? 
Despite crypto's growing mainstream and institutional acceptance, many still view the sector with apprehension and caution. Its reputation as a vehicle for illicit activities continues to undermine its critical use case in the future of finance. While, of course, blockchain does not equate to crypto, the technology&#8217;s interconnectivity with digital currency has become so synonymous that blockchain has faced the unintended consequences of crypto's volatility.
What we need today is more concerted efforts to educate and inform, ensuring that ignorance doesn't become a barrier to the adoption of innovative technologies and new currencies. In doing so, we can strengthen the financial ecosystem at large, ensuring the longevity of the blockchain and crypto sectors.
How are regulatory pressures and market volatility shaping the current and future landscape of the crypto industry worldwide? 
As the digital assets sector is still in its nascent stage, regulators are often playing catch up to understand how best to set guardrails to protect consumers and companies alike. In doing so, they tend to apply existing policies and approaches to the entirely new ecosystem which often run counter to the nature of Web3, resulting in ill-fitting solutions to emerging challenges. &nbsp;While regulations to shield users without impeding DeFi innovation still need to be developed, we're seeing encouraging signs of policies and initiatives that are accelerating the acceptance and adoption of crypto. Singapore, for example, is one such lighthouse jurisdiction that continues to play a leading role in the safe adoption of digital assets through regulatory clarity and oversight for digital asset exchanges and service providers.
Cross-industry collaboration is critical to developing a deeper understanding of blockchain technology and advancing the ecosystem's maturity. At EMURGO, we are committed to continuing our work with policymakers and industry stakeholders around the globe, helping unlock blockchain's full potential. Together, we aim to drive innovation, enhance security, and create more efficient, transparent systems for everyone.

News

Interview

EMURGO's Nikhil Joshi: Cross-Industry Collaboration Critical For Developing A Deeper Understanding Of Blockchain Tech

At just 27, Karoline Leavitt is set to make history as the youngest-ever White House press secretary under Donald Trump&#8216;s next administration.
Trump is betting big on Leavitt, calling her sharp, tough, and a communications powerhouse who&#8217;ll be key in amplifying his &#8220;Make America Great Again&#8221; message from the podium, <a href="https://www.bbc.com/news/articles/cvgep2lexy4o" target="_blank" rel="noreferrer noopener">reported</a> BBC.
According <a href="https://www.politico.com/news/2024/11/15/karoline-leavitt-press-secretary-trump-00189456" target="_blank" rel="noreferrer noopener">to</a> Politico, Leavitt&#8217;s appointment as press secretary is all set, since the staff post does not require Senate confirmation.
A native of New Hampshire, Leavitt&#8217;s career in communications began during her time at Saint Anselm College, where she studied communications and political science. While still in school, she interned at Fox News and in Trump&#8217;s White House press office, which sparked her interest in press relations.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/24/11/41966992/obama-era-state-secretary-warns-trumps-plans-to-withdraw-from-paris-agreement-would-cede-leadership-to-china" rel="noreferrer noopener">Obama-Era State Secretary Warns Trump&#8217;s Plans To Withdraw From Paris Agreement Would &#8216;Cede Leadership To China&#8217;</a>
Leavitt joined the Trump administration in 2019 as a presidential speechwriter before transitioning to assistant press secretary, BBC noted. She worked closely with Press Secretary Kayleigh McEnany to prepare for high-pressure briefings and advocated against what she saw as biased media coverage.
After leaving the White House, Leavitt served as communications director for Rep. Elise Stefanik (R-N.Y.). In 2022, she ran for Congress in New Hampshire&#8217;s first district, securing the Republican nomination but ultimately losing in the general election.
In January 2024, Leavitt rejoined Trump&#8217;s campaign for the 2024 presidential election as press secretary.
Now, she is set to take on the iconic role of White House press secretary, following in the footsteps of past Trump administration spokespeople like Sean Spicer, Sarah Huckabee Sanders, and McEnany.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/11/41890244/elizabeth-warren-says-trump-and-his-transition-team-are-already-crossing-legal-boundaries-i-would-know-because-i-wrote-the-law?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Elizabeth Warren Says Trump And His Transition Team Are Already Crossing Legal Boundaries: ‘I Would Know Because I Wrote The Law'</a></li>
</ul>
Photo: Wikimedia Commons

Politics

Markets

Media

General

Leavitt Set To Become Youngest-Ever White House Press Secretary

Billionaire investor Mark Cuban has pledged $1 million to BucketGolf, a firm that sells portable golf courses, despite his well-known distaste for the sport. The offer was made during an episode of ABC&#8217;s &#8220;Shark Tank.&#8221;
What Happened: BucketGolf, a San Francisco-based company run by siblings Tyler and Jenny Simmons, was seeking $1 million for a 10% equity stake. 
The company, which sells a game that mimics golf using foldable buckets as holes, was projected to generate over $12 million in sales in 2024.
According <a href="https://www.cnbc.com/2024/10/29/mark-cuban-hates-golf-still-offered-bucketgolf-million-dollars-shark-tank.html">to</a> CNBC report, other &#8220;Shark Tank&#8221; panelists, including Kevin O&#8217;Leary and Daymond John, also offered $1 million but for larger equity stakes in BucketGolf. However, Cuban countered with a $1 million offer for 15% of the company, which was less equity than his fellow judges demanded.
Also Read: <a href="https://www.benzinga.com/news/24/10/41196856/heres-how-mark-cubans-drunken-splurge-of-125-000-turned-into-a-profitable-investment">Mark Cuban Drunkenly Bought A $125,000 Lifetime Flight Pass And Turned It Into A Profitable Investment</a>
Initially, the Simmons siblings requested Cuban for 12.5% equity, but he refused. Despite this, Cuban eventually agreed to their terms after fellow judge Lori Greiner did the same. The siblings accepted Cuban&#8217;s offer, citing his sports background as a key factor in their decision.
As of now, it is not clear whether the deal was finalized after the taping. BucketGolf has not responded to CNBC&#8217;s request for comment.
Also Read:&nbsp;<a href="https://www.benzinga.com/top-stories/24/06/39241650/heres-how-mark-cuban-made-91-of-his-employees-millionaires" target="_blank" rel="noreferrer noopener">Here's How Mark Cuban Made 91% Of His Employees Millionaires</a>
Why It Matters: This investment is noteworthy given Cuban&#8217;s public dislike for golf. His decision to invest in BucketGolf, despite his personal preferences, underscores his belief in the company&#8217;s potential and the innovative nature of its product. 
The Simmons siblings&#8217; decision to accept Cuban&#8217;s offer, despite his initial refusal, also highlights the value they place on his sports industry experience. This move could potentially boost the company&#8217;s profile and growth in the sports entertainment market.
Read Next
<a href="https://www.benzinga.com/news/24/08/40667225/mark-cuban-asks-his-8m-x-followers-about-whose-character-would-they-like-young-children-to-grow-up-e" target="_blank" rel="noreferrer noopener">Mark Cuban Asks His 8M X Followers About Whose Character Would They Like Young Children To Grow Up Emulating Between Trump And Harris: Cuban Receives Half A Million Responses, Majority Supporting This Candidate</a>
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Image: Shutterstock

Success Stories

Mark Cuban Swings $1M To Golf Company Despite Hating The Sport

The FBI is investigating a series of offensive and racist text messages targeting various communities across the United States, including African American, Black, <a href="https://www.benzinga.com/markets/24/11/41868203/trump-made-big-gains-among-latino-working-class-and-younger-voters" target="_blank" rel="noreferrer noopener">Hispanic, and LGBTQIA+ groups</a>, in the wake of the presidential election.
The disturbing messages, which reference the reintroduction of slavery and plantation labor, are now being sent even to include high school students, per a <a href="https://www.fbi.gov/news/press-releases/fbi-statement-regarding-offensive-text-messages" target="_blank" rel="noreferrer noopener">statement</a> from the FBI. In some cases, recipients have reported receiving messages about deportation or being selected for re-education camps. Some of the messages have also been sent via email.
While no violent incidents have been reported, the FBI said it is working closely with the Justice Department and other federal authorities to address the issue.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/cannabis/24/09/41002710/your-cousins-in-florida-like-their-weed-why-hispanic-voters-could-tip-the-scale-for-cannabis-wil" rel="noreferrer noopener">Your Cousins In Florida Like Their Weed: Why Hispanic Voters Could Tip The Scale For Cannabis,Will It Be Enough</a>
The agency is also in contact with the Department of Justice&#8217;s Civil Rights Division and is collaborating with law enforcement partners, community organizations, and leaders in academia and faith communities to investigate and address these offenses. The FBI continues to evaluate all reported incidents and remains committed to protecting civil rights.
In comments <a href="https://www.theguardian.com/us-news/2024/nov/15/homophobic-anti-migrant-texts-election-fbi">to The Guardian</a>, President-elect Donald Trump&#8216;s spokesperson Steven Cheung denied any connection between the campaign and the racist text messages.
The NAACP condemned the messages, calling them a disturbing rise in hateful rhetoric from racist groups. NAACP President Derrick Johnson linked the messages to the actions of Trump who, he said, has historically encouraged hate, The Guardian added.
The NAACP emphasized the need to address the growing fear and division caused by such messages.
Also Read:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41814589/why-trumps-boost-to-treasury-yields-inflation-expectations-may-weaken-feds-efforts-" target="_blank" rel="noreferrer noopener">Why Trump&#8217;s Boost To Treasury Yields, Inflation Expectations May Weaken Fed&#8217;s Efforts To Cut Interest Rates</a></li>
</ul>

FBI Investigating Racist Text Message Campaign Following Election

Bitcoin might be making headlines for hitting an all-time high after the U.S. presidential election, but an even more impressive success story is unfolding. While the world&#8217;s most popular cryptocurrency is <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41709166/bitcoin-to-hit-100-000-by-january-2025-could-black-hole-effect-push-the-largest-crypto-to-">nearing the $100,000 milestone</a>, Nvidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) has outperformed Bitcoin significantly over the past five years.
Don't Miss:
<ul>
<li>With over 7.8K investors including Meta, Google, And Amazon Execs — this AI Startup's valuation has skyrocketed from $5 million to $85 million in just three years. <a href="https://www.benzinga.com/money/rad-ai"><a href="https://www.benzinga.com/money/rad-ai-2">Be an early investor with just $1,000 for only $0.50/share today before the offer closes next week</a>!</a></li>
<li>1 in 4 Americans own a share of Bitcoin according to NASDAQ — <a href="https://www.benzinga.com/money/binance-100">this platform touts returns as high as 12.5% APY and is giving $100 in welcome rewards if you sign up today.</a></li>
</ul>
<a href="https://www.benzinga.com/quote/BTC-USD">Bitcoin</a> has had an incredible year. Since the 2024 presidential election, it has been on a rapid upward climb, <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41951961/bitcoin-to-100k-benzinga-readers-predict-if-btc-can-hit-new-milestone-before-end-of-2024">recently hitting $93,434.36</a> and approaching the much-anticipated six-figure mark.&nbsp;
Changing regulations, growing institutional interest and especially <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41770352/bitcoins-future-under-president-elect-donald-trump-a-look-at-his-crypto-policies">pro-crypto sentiments</a> from the future U.S. leadership have all contributed to Bitcoin&#8217;s rise. Many analysts now expect it might hit $100,000 sooner rather than later and the enthusiasm is evident.
Trending: ‘Scrolling Through UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">Valuation set to change next week but you can invest TODAY for just $0.25/share with a $1000 minimum</a>.
But while Bitcoin has been gaining attention, Nvidia&#8217;s stock has been outperforming it. On Nov. 14, Nvidia&#8217;s share price closed at $146.27, a staggering 2,768% increase over the previous five years. To put things in perspective, Bitcoin has increased by roughly 973% during that time, which is remarkable but still significantly less than Nvidia&#8217;s enormous growth.
The tech sector now relies heavily on Nvidia. Their specialist chips have been in high demand as artificial intelligence (AI) becomes a more important component of everything from data centers to consumer goods. The company has experienced exponential growth and its stock price has followed suit.
See Also: The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"> for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a>
<h2 class="wp-block-heading">Nvidia Joins the Dow</h2>
Among Nvidia&#8217;s recent accomplishments is replacing Intel in the Dow Jones Industrial Average. This action emphasizes the continuous transition toward AI technology and firmly establishes Nvidia as a significant force in the tech sector. With a market cap of $3.43 trillion, <a href="https://www.benzinga.com/news/large-cap/24/11/41761849/nvidia-blows-past-apple-to-become-worlds-most-valuable-company">Nvidia recently surpassed Apple</a> to become the world&#8217;s most valuable company.
<a href="https://www.benzinga.com/insights/options/24/11/41951342/spotlight-on-nvidia-analyzing-the-surge-in-options-activity">Analysts have remained bullish on Nvidia</a>, citing its continued dominance in AI chips and the growth of AI technology overall. The company&#8217;s future looks bright, with analysts setting price targets that suggest even more upside potential for investors.
Although Bitcoin&#8217;s ascent to its highest point in history is undoubtedly cause for celebration, Nvidia&#8217;s achievements over the last five years are truly remarkable. While both Nvidia and Bitcoin have provided investors with amazing profits, Nvidia has been one of the market leaders due to its steady expansion and rising product demand. Use <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> to stay informed about the latest NVIDIA options trades with real-time alerts.
Read Next:
<ul>
<li>This Adobe-backed AI marketing startup went from a $5 to $85 million valuation working with brands like L'Oréal, Hasbro, and Sweetgreen in just three years –<a href="https://www.benzinga.com/money/rad-ai"> here's how there's a limited time opportunity to invest at $1,000 for only $0.50/share before closing date.</a></li>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?</li>
</ul>

Startups

NVDA

Bitcoin Hits An All-Time High, But Nvidia Has Outperformed It Dramatically Over The Last Five Years

A Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) investor has demonstrated the potential of long-term investment in digital assets by turning a mere $120 into a staggering $179 million over a 14-year period.
What Happened: A Bitcoin whale moved 2,000 Bitcoin, now worth $179 million, which had been untouched for 14 years.
Blockchain data indicates that the whale received the coins in 2010 when they were valued at just $0.06 each, making the total value of the coins at that time $120.
The investor transferred the Bitcoin to the American crypto exchange, Coinbase, last week, after seeing their holdings appreciate by nearly 150,000,000%. This move is presumed to be a step towards selling the digital asset.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">JUST IN: Someone just moved 2,000 <a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> worth $179,000,000. They held from $0.06 to $90,000 Legend &#x1f525; <a href="https://t.co/L2nprLATnh">pic.twitter.com/L2nprLATnh</a>
&mdash; The Bitcoin Historian (@pete_rizzo_) <a href="https://twitter.com/pete_rizzo_/status/1857428085647306914?ref_src=twsrc%5Etfw">November 15, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<figcaption class="wp-element-caption">Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41869087/kiyosaki-aims-to-own-100-bitcoins-by-2025-i-wish-bitcoin-was-back-to-10-a-coin-but-wishing-has-never-made-poor-people-richer">Kiyosaki Aims To Own 100 Bitcoins By 2025: &#8216;I Wish Bitcoin Was Back To $10 A Coin, But Wishing Has Never Made Poor People Richer&#8217;</a></figcaption></figure>
Currently, Bitcoin is valued at $90,476, according to Benzinga data. It reached an all-time high of over $93,000 last week, marking an increase of about $20,000 since Election Day.
Why It Matters: Bitcoin whales, as they are known in the crypto world, are investors who accumulate large amounts of digital coins and hold onto them for years, watching their value increase exponentially. 
Despite short-term volatility, Bitcoin typically appreciates more than most other assets in the long run, yielding substantial returns for those who hold onto it, known as &#8220;HODLers.&#8221;
This story serves as a testament to the potential of long-term investment in digital assets.
Read Next
<a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42024635/scaramucci-trumps-crypto-support-could-push-bitcoin-to-150k">Scaramucci: Trump&#8217;s Crypto Support Could Push Bitcoin To $150K</a>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Here's How A Bitcoin Whale Nets $179M From A $120 Investment

Billionaire Elon Musk and former Republican presidential candidate Vivek Ramaswamy have set their sights on curbing federal expenditure, leveraging the Republican dominance <a href="https://www.benzinga.com/news/24/09/41082363/heres-how-elon-musk-has-become-a-pro-trump-political-influencer-through-social-media">in both chambers of Congress</a>.
What Happened: According to a report, the duo&#8217;s Department of Government Efficiency (DOGE) aims to reduce spending by a whopping $2 trillion. 
The Republican majority in Congress, which allows for budget reconciliation, makes this ambitious target more attainable by sidestepping the usual filibuster rules.
Business Insider reports that <a href="https://www.businessinsider.com/why-elon-musk-cutting-federal-spending-could-work-2024-11">the</a> Department of Government Efficiency is not a government entity. Major alterations to the federal budget will likely necessitate legislative intervention. Nevertheless, Musk and Ramaswamy are in a strong position to recommend significant reductions in federal spending.
David Walker, a fiscal watchdog who headed the Government Accountability Office from 1998 to 2008, told the outlet about the limitations on what can and cannot be done, underlining the difficulties previous presidents have encountered in managing federal spending.
&#8220;There are a lot more restrictions on what you can and can&#8217;t do. There&#8217;s a lot of cultural barriers,&#8221; he said. 
The efforts by Musk and Ramaswamy could surpass prior attempts. Any proposals endorsed by Trump would have a higher likelihood of gaining Congressional approval due to Republican control. 
Also Read: <a href="https://www.benzinga.com/news/24/11/41965420/elon-musk-vivek-ramaswamy-led-department-of-government-efficiency-opens-account-on-x-says-it-is-working-overtime">Elon Musk, Vivek Ramaswamy-Led Department Of Government Efficiency Opens Account On X</a>
Thomas Schatz, the president of Citizens Against Government Waste, believes this government-efficiency initiative &#8220;can be set up faster.&#8221;
Musk has previously expressed his disapproval of the Securities and Exchange Commission and proposed incentives for government employees who demonstrate fiscal prudence. 
Ramaswamy has suggested a thought experiment to downsize the federal workforce. Veronique de Rugy, an economist at the libertarian think tank Mercatus Center, believes that Musk and Ramaswamy could achieve $2 trillion in savings through radical reforms.
Why It Matters: This development is significant in the context of ongoing debates about federal spending and debt. 
The ambitious plan by Musk and Ramaswamy, if successful, could set a precedent for future administrations and potentially reshape the landscape of government spending. 
Their unique approach, coupled with the current political climate, may provide the necessary momentum to drive significant changes in federal expenditure.
Read Next
<a href="https://www.benzinga.com/news/24/07/39999410/what-a-second-trump-presidency-would-mean-for-elon-musk-and-his-many-ventures">What A Second Trump Presidency Would Mean For Elon Musk And His Many Ventures</a>
This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.

Musk And Ramaswamy Seek Spending Cut Wins Where Others Failed

<a href="https://www.benzinga.com/personal-finance/24/09/40972049/dave-ramsey-tells-29-year-old-1m-in-debt-and-spending-like-shes-in-congress-im-getting-ready-to-">Dave Ramsey isn't just any financial guru – </a>he's a powerhouse who reportedly owns $600 million in real estate, all bought in cash. Known for his unfiltered advice to callers, he usually sticks to helping others get their finances straight. But occasionally, he pulls back the curtain and gives a glimpse into the personal strategies that got him where he is.
Don't Miss:
<ul>
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
<li>This Jeff Bezos-backed startup will allow you to<a href="https://www.benzinga.com/money/bezos-landlord-100-dollars"> become a landlord in just 10 minutes, and you only need $100</a>.</li>
</ul>
A few years back, in a popular YouTube video, Ramsey's message was loud and clear: "The borrower is a slave to the lender."
In that video, he detailed his investing process, clarifying that debt isn't just a financial burden – it's a roadblock to real wealth. For Ramsey, avoiding debt isn't simply about managing money; it's about <a href="https://www.benzinga.com/personal-finance/24/09/40711869/how-rich-are-you-heres-the-net-worth-that-defines-upper-middle-and-lower-class">taking control of your future</a>.
Ramsey often highlights the power of focusing on "your most powerful wealth-building tool" – your income. He insists that when you keep your earnings out of the hands of lenders, you're free to use them to create long-term wealth. "When you haven't committed your income in the form of payments to everybody else, you can invest it and become wealthy," he says, explaining that a little financial discipline now can lead to significant rewards.
Trending: ‘Scrolling to UBI': Deloitte's #1 fastest-growing software company allows users to earn money on their phones –<a href="https://www.benzinga.com/money/mode-mobile-2"> invest today with $1,000 for just $0.25/share</a>
Ramsey shares a striking example: the average car payment in America is around $503. "That's just crazy," he exclaims. If someone instead invested $500 a month from age 30 to 70 in a decent growth stock mutual fund, Ramsey claims they could amass over five million dollars by retirement. "One thing could make you worth five million dollars," he says, emphasizing how small decisions add up over time.
<a href="https://www.benzinga.com/personal-finance/24/09/40777048/24-year-old-gets-best-job-of-his-life-and-wants-to-invest-but-dave-ramsey-says-youre-broke-and-i">Ramsey's advice</a> doesn't stop at avoiding debt. He's also a vocal advocate for investing in good growth stock mutual funds, a strategy he believes is the best path to financial independence. He favors a balanced approach, spreading investments across four types of funds: growth and income, growth, aggressive growth and international funds. This mix, he argues, has a strong track record of outperforming basic index funds. "If the mutual fund you're looking at is below that S&amp;P 500 line, don't buy that fund," he advises.
Trending: This rooftop wind turbine is taking on a market projected to reach over $900 billion by 2032 —<a href="https://www.benzinga.com/money/halcium"> With already over 40,000 users signing up to purchase, here's a chance to be an early investor today!</a>
Ramsey is well aware that his stance sometimes contrasts with other voices in the financial world, especially those promoting index funds and fee-conscious strategies. "Some people are stepping over $5 bills trying to pick up pennies worrying about these fees," he quips, adding that while fees matter, they're not what makes or breaks financial success. To him, the true key is consistency – saving and investing monthly, year after year, no matter what the market is doing. He's clear that "the big thing is actually putting money into the mutual funds, actually investing."
Ramsey's approach also reflects his view on financial independence. For him, paying a broker is worth it to have someone keep you on track. "I need a broker in my life. I need somebody that's an advisor," he says, explaining that, despite knowing a lot about investing, he <a href="https://www.benzinga.com/money/can-you-guess-how-many-americans-successfully-retire-with-1-million-saved">prefers having a professional's guidance</a> to stay disciplined. Ramsey points out that emotional reactions to market trends often sway people who invest independently. "When you're out there by yourself with all your theories," he says, "you cash out all your mutual funds at exactly the wrong time because you don't have anybody in your corner saying, ‘Don't jump.'"
See Also: Many are using this retirement income calculator to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on how on what&#8217;s behind this formula.</a>
According to Ramsey, retirement success isn't just about choosing the right investments – it's about regularly investing. He cites research showing that "74% of retirement success is doing it." By steadily contributing to retirement accounts, people can build a significant nest egg without chasing high returns or jumping in and out of the market.
Ramsey's advice is simple: <a href="https://www.benzinga.com/personal-finance/24/10/41385340/dave-ramsey-says-buying-cars-for-your-teenagers-leads-to-a-lifetime-of-ridiculous-expectations-b">stay away from debt</a>, invest consistently and focus on the long term. He believes this advice can help people achieve not only wealth but also peace of mind. "This is how you get wealthy," he says, stressing that the journey isn't about luck or timing; it's about persistence and discipline.
Read Next:
<ul>
<li>Studies show 50% of consumers think Financial Advisors cost much more than they do —<a href="https://www.benzinga.com/money/money-pickle"> to debunk this, this company provides matching for free and a complimentary first call with the matched advisor.</a></li>
<li><a href="https://www.benzinga.com/money/62-years-old-with-1-mil-saved">I&#8217;m 62 Years Old And Have $1.2 Million Saved. Is This Enough to Retire Stress-Free?</a></li>
</ul>

Personal Finance

'This Is How You Get Wealthy' – Dave Ramsey Details How One Move Could Make You $5 Million By Retirement

European banks are bracing for intensified competition as U.S. President-elect <a href="https://www.benzinga.com/markets/24/11/41916450/just-how-bullish-is-the-market-on-trumps-election-win-to-find-out-look-to-the-past">Donald Trump</a> prepares to roll out policies to deregulate the U.S. financial sector. Trump's promise to ease financial regulations is expected to benefit American banks by boosting their lending and investment capacity.&nbsp;
Don't Miss:
<ul>
<li>Over the last five years, the price of gold has increased by approximately 83% — Investors like Bill O&#8217;Reilly and Rudy Giuliani are using this platform to <a href="https://www.benzinga.com/money/american-hartford-gold">create customized gold IRAs to help shield their savings from inflation and economic turbulence.&nbsp;</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target –<a href="https://www.benzinga.com/money/mode-mobile-2"> You can still get 4,000 of its pre-IPO shares for just $1,000</a></li>
</ul>
Meanwhile, <a href="https://www.benzinga.com/news/24/10/41379867/european-central-bank-lowers-interest-rates-again-first-back-to-back-cuts-in-13-years">European banks</a> may struggle to keep up under Europe's stringent regulations and slower economic growth, potentially widening the earnings gap across the Atlantic.&nbsp;
Under the Trump administration, U.S. banks anticipate that restrictions on capital requirements, merger approval timelines and oversight of complex investments will be loosened. Wall Street is already optimistic about this potential wave of deregulation, with American banking giants like <a href="https://www.benzinga.com/markets/24/11/41852613/jp-morgan-analysts-see-generational-opportunity-in-real-estate-market-as-a-direct-result-of-valuatio">JPMorgan</a>, Goldman Sachs and Morgan Stanley seeing a rise in shares following the election.&nbsp;
This increased flexibility in lending and investments could position U.S. banks to outpace their European counterparts.&nbsp;
Trending: This Adobe-backed AI marketing startup went from a $5 to $85 million valuation working with brands like L'Oréal, Hasbro, and Sweetgreen in just three years –<a href="https://www.benzinga.com/money/rad-ai"> <a href="https://www.benzinga.com/money/rad-ai-2">Be an early investor with just $1,000 for only $0.50/share today before the offer closes in next week</a>!</a>
European banks, which have long struggled with lower profitability largely due to the 2008 financial crisis, now face further challenges. Lenders in Europe have battled against weak economies, low interest rates and an oversupply of nonperforming loans. While some European banks had started to recover in 2023, the shift in regulations on U.S. banks could have a negative impact.&nbsp;
David Materazzi, CEO of Galileo FX, an Italy-based automated trading platform, believes that U.S. banks will take advantage of the looser regulatory environment. He told Reuters, "If U.S. banks get the expected policy support, they could ramp up loan volumes and optimize capital in ways that Europe's banks just can't match right now."
Trending: The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"> for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a>
With American banks likely to experience fewer regulatory barriers, experts believe that European lenders could be pressured to reevaluate their strategies to compete globally. European Union regulations remain strict, with capital requirements and risk assessments that prevent banks from taking on the same level of <a href="https://www.benzinga.com/startups/24/09/40922382/oracle-of-omaha-sends-a-warning-buffetts-aggressive-bank-of-america-stock-sales-raise-eyebrows">aggressive investments</a> seen on Wall Street. These tighter controls are designed to prevent another crisis but also restrict banks&#8217; ability to grow profit margins significantly.
Additionally, the contrasting regulatory paths between the U.S. and Europe could influence how investors view each region's banks. As U.S. banks potentially increase their profits through higher loan volumes and new investments, European banks may look less appealing, especially if they don't see the necessary growth to compete. Analysts suggest this shift could drive investors to favor U.S. financial institutions over European ones, deepening the trans-Atlantic divide.
See Also: ‘Scrolling to UBI': Deloitte's #1 fastest-growing software company allows users to earn money on their phones –<a href="https://www.benzinga.com/money/mode-mobile-2"> invest today with $1,000 for just $0.25/share</a>
Promises of a shifting regulatory landscape in the U.S. have prompted leaders in European financial hubs to reassess their own policies. Recently, Swiss Finance Minister Karin Keller-Sutter and her British counterpart Rachel Reeves discussed the potential impact Trump's election could bring on banking regulations.&nbsp;
Keller-Sutter told Reuters that she and Reeves agreed it was important to balance competitiveness with stability.&nbsp;
While European and U.S. banks alike brace for the coming changes, the next few years could redefine the banking landscape across both continents. As U.S. banks potentially take advantage of looser regulations, European lenders may face pressure to innovate or advocate for regulatory flexibility. However, for now, the two continents appear set to diverge on policy and regulators and the global financial community will closely watch the impact of these changes.
Read Next:
<ul>
<li>With over 7.8K investors including Meta, Google, And Amazon Execs — this AI Startup's valuation has skyrocketed from $5 million to $85 million in just three years. <a href="https://www.benzinga.com/money/rad-ai">Be an early investor with just $1,000 for only $0.50/share today before the offer closes in 2 weeks.</a></li>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?</li>
</ul>

Banking Showdown: European Lenders Face New Hurdles As Trump Lifts U.S. Restrictions

<a href="https://www.theinformation.com/articles/nvidia-customers-worry-about-snag-with-new-ai-chip-servers" title="https://www.theinformation.com/articles/nvidia-customers-worry-about-snag-with-new-ai-chip-servers">https://www.theinformation.com/articles/nvidia-customers-worry-about-snag-with-new-ai-chip-servers</a>

Tech

The Information Reported Sunday, Nvidia Customers Worry About Snag With New AI Chip Servers

<a href="https://www.wsj.com/business/media/nba-warner-bros-discovery-lawsuit-settlement-7710547b?mod=Searchresults_pos1&amp;page=1" title="https://www.wsj.com/business/media/nba-warner-bros-discovery-lawsuit-settlement-7710547b?mod=Searchresults_pos1&amp;page=1">https://www.wsj.com/business/media/nba-warner-bros-discovery-lawsuit-settlement-7710547b?mod=Searchresults_pos1&amp;page=1</a>

Legal

The Wall Street Journal Reported Saturday, Warner Bros. Discovery, NBA Resolved TV Rights Legal Dispute; TNT's 'Inside The NBA' Licensed To ESPN; Warner Gains Some International NBA Game Rights

As the U.S. retirement market faces unprecedented challenges and opportunities, financial advisors must adapt their approach to better serve clients. 
Recent data from ISS Market Intelligence, as reported by <a href="https://www.planadviser.com/us-retirement-market-evolves-amid-growth-challenges/">Planadviser</a>, reveals several critical areas where advisors need to enhance their service offerings and expertise.
First, advisors must address the growing retirement coverage gap. With approximately one-third of U.S. adults lacking dedicated retirement savings, advisors should actively seek opportunities to partner with small businesses that currently don&#8217;t offer retirement plans. The SECURE 2.0 Act provides new incentives for small business plan adoption, creating an untapped market of roughly 6 million businesses without 401(k) plans.
Advisors need to strengthen their role as educators, particularly regarding Social Security optimization, according to ISS Market Intelligence. With lower-income earners expecting to rely on Social Security for more than 50% of their retirement income, advisors must help clients understand the implications of this dependence and develop strategies to diversify income sources.
Also Read: <a href="https://www.benzinga.com/general/sports/24/11/42015289/disney-q4-report-had-a-lot-to-like-analyst-calls-it-a-high-quality-profit-growth-performer">Disney Q4 Earnings Show &#8216;A Lot To Like&#8217;: Analyst Calls It &#8216;High-Quality&#8217; Profit Growth Performer</a>
The aging workforce presents another critical challenge requiring advisor attention. As Baby Boomers retire, creating net-negative cash flows in defined contribution plans, advisors must develop sophisticated decumulation strategies while encouraging younger generations to increase their retirement savings. 
This includes leveraging automatic features, which are currently underutilized in 63% of retirement plans despite their proven effectiveness in driving asset growth.
Financial literacy advocacy should become a core component of advisor services. With retirement assets now comprising 40% of total family wealth, advisors must ensure clients understand their options and make informed decisions about their retirement planning.
By focusing on these areas, advisors can better serve their clients while contributing to the broader goal of improving retirement security for all Americans.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/11/42015996/tesla-to-partner-with-lyft-uber-analyst-says-rising-conviction-for-partnership-in-future">Tesla To Partner With Lyft, Uber? Analyst Has &#8216;Rising Conviction&#8217; For Future Partnership</a></li>
</ul>
Image via Pexels/ Tima Miroshnichenko

Financial Advisors

Advisors Need To Step Up To Help Americans Save For Retirement

These seven mid-cap stocks were the best performers in the last week. Are they in your portfolio?
<ol>
<li>Bloom Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) stock gained 55.44% last week after several analysts <a href="https://www.benzinga.com/quote/be/analyst-ratings" target="_blank" rel="noreferrer noopener">raised their price forecasts</a> on the stock.</li>
<li>Rocket Lab USA, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) stock upped 29.96% after the company reported financial results and announced a multi-launch agreement with a confidential commercial satellite constellation operator and a federal defense <a href="https://www.benzinga.com//node/41941068" target="_blank" rel="noreferrer noopener">contract worth up to $8 million</a>.</li>
<li>NET Power Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NPWR#NYSE">NPWR</a>) stock gained 39.38% last week. The company <a href="https://www.benzinga.com//node/41888013" target="_blank" rel="noreferrer noopener">reported Q3 financial results</a> and provided updates on its cash and balance sheet.</li>
<li>Hut 8 Mining (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUT#NASDAQ">HUT</a>) shares gained 28.98% last week after the company reported better-than-expected Q3 financial results. Several analysts <a href="https://www.benzinga.com/quote/hut/analyst-ratings" target="_blank" rel="noreferrer noopener">raised their price forecasts</a> on the stock.</li>
<li>Paymentus Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAY#NYSE">PAY</a>) shares surged 23.84% after the company reported <a href="https://www.benzinga.com//node/41936928" target="_blank" rel="noreferrer noopener">strong earnings and guidance</a>.</li>
<li>DLocal Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLO#NASDAQ">DLO</a>) shares jumped 17.74% after the company<a href="https://www.benzinga.com//node/41974555" target="_blank" rel="noreferrer noopener"> reported third-quarter results</a>.</li>
<li>IonQ, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>) shares increased 17.55% after the company announced a strengthened moat<a href="https://www.benzinga.com//node/41945075" target="_blank" rel="noreferrer noopener"> through a series of issued patents</a>.</li>
</ol>
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/24/11/42026369/shopify-disney-and-coinbase-were-among-top-10-large-cap-gainers-last-week-november-11-15-are-the-others-in-your-portfolio" target="_blank" rel="noreferrer noopener">Shopify, Disney And Coinbase Were Among Top 10 Large Cap Gainers Last Week (November 11-15): Are The Others In Your Portfolio?</a></li>
<li><a href="https://www.benzinga.com/news/large-cap/24/11/42026470/super-micro-computer-moderna-and-xpeng-were-among-top-10-large-cap-stocks-losing-big-last-week-november-11-15-check-out-other-losers" target="_blank" rel="noreferrer noopener">Super Micro Computer, Moderna And XPeng Were Among Top 10 Large Cap Stocks Losing Big Last Week (November 11-15): Check Out Other Losers</a></li>
</ul>
Photo via Shutterstock

Mid Cap

Movers

Trading Ideas

IONQ

NPWR

RKLB

Rocket Lab And Hut 8 Mining Are Among Top 7 Mid-Cap Gainers Last Week (November 11-15): Are The Others In Your Portfolio?

Billionaire Elon Musk , a confidante of President-elect Donald Trump, has thrown his support behind Howard Lutnick, CEO of Cantor Fitzgerald, for treasury secretary.
What Happened: Musk believes that Lutnick could bring about significant change if chosen for the position. Although Trump has not yet officially named his choice, Lutnick and investor Scott Bessent are said to be the leading candidates.
In a post on X on Saturday, Musk shared his opinion that Bessent would represent a &#8220;business-as-usual choice,&#8221; whereas Lutnick could instigate the change that conservatives are hoping for in Trump&#8217;s second term.
&#8220;Business-as-usual is driving America bankrupt, so we need change one way or another,&#8221; Musk stated.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Would be interesting to hear more people weigh in on this for <a href="https://twitter.com/realDonaldTrump?ref_src=twsrc%5Etfw">@realDonaldTrump</a> to consider feedback. My view fwiw is that Bessent is a business-as-usual choice, whereas <a href="https://twitter.com/howardlutnick?ref_src=twsrc%5Etfw">@howardlutnick</a> will actually enact change. Business-as-usual is driving America bankrupt, so we need change… <a href="https://t.co/igGLZOJ8wz">https://t.co/igGLZOJ8wz</a>
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1857819784865362211?ref_src=twsrc%5Etfw">November 16, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The Treasury Secretary will have a pivotal role in the new administration, given the major economic challenges that played a part in Trump&#8217;s election win. 
Also Read:&nbsp;<a href="https://www.benzinga.com/news/24/07/39999410/what-a-second-trump-presidency-would-mean-for-elon-musk-and-his-many-ventures" target="_blank" rel="noreferrer noopener">What A Second Trump Presidency Would Mean For Elon Musk And His Many Ventures</a>
Despite low unemployment rates and economic growth, many Americans are discontented with high costs and perceived widespread inflation.
Lutnick, who has known Trump for many years, has organized fundraisers for the President-elect and served as a TV surrogate. Conversely, Bessent, the founder of macro hedge fund Key Square Group, was a principal economic advisor to Trump during his campaign.
Why It Matters: The selection of the Treasury Secretary is a critical decision for the incoming administration. The chosen candidate will be tasked with addressing the economic issues that have been a significant factor in Trump&#8217;s election. 
The endorsement from Musk, a prominent figure in the business world, could potentially influence the final decision. 
The contrasting backgrounds of Lutnick and Bessent highlight the different approaches that could be taken to address the economic challenges facing the country.
Read Next
<a href="https://www.benzinga.com/news/24/09/41082363/heres-how-elon-musk-has-become-a-pro-trump-political-influencer-through-social-media">Here&#8217;s How Elon Musk Has Become A Pro-Trump Political Influencer Through Social Media</a>
This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Image: Shutterstock

Musk Pushes Lutnick For Trump's Treasury Secretary

These ten large-cap stocks were the worst performers in the last week. Are they in your portfolio?
<ol>
<li>Monolithic Power Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MPWR#NASDAQ">MPWR</a>) lost 24.68% last week as it was hit by an Edgewater Research analyst report that stated Monolithic's allocation to Nvidia's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) Blackwell GPUs is in jeopardy due to performance problems with its Power Management ICs.</li>
<li>Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) stock tumbled 24.23% after the company recently announced it could not file its quarterly report for the period ending <a href="https://www.benzinga.com//node/41938588" target="_blank" rel="noreferrer noopener">September 30, 2024, on time</a>.</li>
<li>Moderna Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) stock fell 21.31% last week amid <a href="https://www.benzinga.com//node/42013119" target="_blank" rel="noreferrer noopener">pressure on vaccine stocks</a> after President-elect Donald Trump nominated Robert F. Kennedy Jr. to lead the HHS.</li>
<li>Leidos Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>) shares dived 19.04%, probably because President-elect Trump made federal appointments during his transition period. Investors may evaluate the impact of possible cuts from the "<a href="https://www.benzinga.com//node/42013424" target="_blank" rel="noreferrer noopener">Department of Government Efficiency."</a></li>
<li>Monday.Com Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>) stock fell 18.94% last week <a href="https://www.benzinga.com//node/41877454" target="_blank" rel="noreferrer noopener">despite the company reporting</a> a Q3 beat and raising its annual outlook.</li>
<li>Vaxcyte, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCVX#NASDAQ">PCVX</a>) stock fell 18.60% last week amid <a href="https://www.benzinga.com//node/42013119" target="_blank" rel="noreferrer noopener">pressure on vaccine stocks</a> after President-elect Donald Trump nominated Robert F. Kennedy Jr. to lead the HHS.</li>
<li>Booz Allen Hamilton Holding Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAH#NYSE">BAH</a>) shares plummeted 18.59%.</li>
<li>AbbVie Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>) stock declined 17.30% last week after it announced that its Phase 2 EMPOWER trials did not <a href="https://www.benzinga.com/general/biotech/24/11/41881546/abbvie-9billion-schizophrenia-studies-bristol-myers-stock-surges" target="_blank" rel="noreferrer noopener">meet their primary endpoints</a>.</li>
<li>CACI International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CACI#NYSE">CACI</a>) shares decreased 17.16%.</li>
<li>XPeng Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) shares dipped 16.89%, reflecting a broader trend in U.S.-listed Chinese stocks. This market shift may be influenced by concerns surrounding President-elect Trump's administration picks, which could <a href="https://www.benzinga.com//node/41946780" target="_blank" rel="noreferrer noopener">signal a tougher stance toward China</a>.</li>
</ol>
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/24/11/42026369/shopify-disney-and-coinbase-were-among-top-10-large-cap-gainers-last-week-november-11-15-are-the-others-in-your-portfolio" target="_blank" rel="noreferrer noopener">Shopify, Disney And Coinbase Were Among Top 10 Large Cap Gainers Last Week (November 11-15): Are The Others In Your Portfolio?</a></li>
</ul>
Image by Robert Way via Shutterstock

Large Cap

ABBV

CACI

LDOS

MNDY

MPWR

MRNA

PCVX

SMCI

XPEV

Super Micro Computer, Moderna And XPeng Were Among Top 10 Large Cap Stocks Losing Big Last Week (November 11-15): Check Out Other Losers

Over the week, the tech world buzzed with significant developments. From potential policy shifts affecting Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) suppliers to Japan&#8217;s leap into the AI industrial revolution, the landscape is changing rapidly. Here&#8217;s a quick roundup of the top stories.
Nvidia, Apple Suppliers Brace for Policy Changes
Key suppliers for Nvidia and Apple, including Hon Hai Precision Industry Co. Ltd. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/HNHPF#OTC">HNHPF</a>), also known as Foxconn, Pegatron Corp. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/PGTRF#OTC">PGTRF</a>), and Quanta Computer (OTC:<a class="ticker" href="https://www.benzinga.com/stock/QUCCF#OTC">QUCCF</a>), are gearing up for a potential surge in U.S. investments amid potential trade policy shifts under a possible second term for Donald Trump.
<a href="https://www.benzinga.com/24/11/42001994/nvidia-and-apple-suppliers-brace-for-trumps-return-foxconn-pegatron-quanta-ready-for-rapid-us-investment-surge-amid-trade-policy-shifts">Read the full article here.</a>
Nvidia and SoftBank&#8217;s AI Supercomputer in Japan
In a significant move towards becoming a global AI powerhouse, Nvidia and SoftBank Group (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SFTBF#OTC">SFTBF</a>) announced a partnership to establish Japan&#8217;s most powerful AI supercomputer. The collaboration, unveiled at the Nvidia AI Summit Japan, will leverage Nvidia&#8217;s advanced Blackwell platform.
<a href="https://www.benzinga.com/news/global/24/11/41929194/nvidia-and-softbank-to-build-japans-top-ai-supercomputer-on-blackwell-platform-jensen-huang-says-tokyo-is-leaping-into-the-ai-industrial-revolution">Read the full article here.</a>
See Also: <a href="https://www.benzinga.com/media/24/11/41927913/amazon-confirms-vendor-data-breach-affecting-2-8m-employee-contacts-adds-to-growing-list-of-moveit-hack-victims?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Amazon Confirms Vendor Data Breach Affecting 2.8M+ Employee Contacts, Adds To Growing List Of MOVEit Hack</a>
AMD&#8217;s Workforce Cut Amid AI Chip Development Shift
Advanced Micro Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) has reportedly decided to lay off approximately 1,000 employees, representing 4% of its global workforce. The move is part of AMD&#8217;s strategic shift towards AI chip development to compete with Nvidia in the data center chip market.
<a href="https://www.benzinga.com/24/11/41961230/amd-plans-to-cut-4-of-workforce-amid-strategic-shift-toward-ai-chip-development-to-rival-jensen-huang-led-nvidias-dominance-report">Read the full article here.</a>
Nvidia&#8217;s Blackwell Chip Revenue Forecast
Ahead of Nvidia&#8217;s third-quarter results announcement next week, Morgan Stanley analyst Joseph Moore has previewed the company&#8217;s outlook. Despite supply constraints on new products, Moore predicts several billion in revenue from Blackwell chips alone in the January quarter, with a more precise figure of between $5 billion and $6 billion.
<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41883803/nvidias-blackwell-chip-revenue-could-hit-6-billion-next-quarter-analyst">Read the full article here.</a>
AI Capabilities Plateau, Say Andreessen Horowitz Founders
The founders of venture capital firm Andreessen Horowitz have noted a plateau in artificial intelligence capabilities, citing data shortages and computational limitations as key barriers. This observation aligns with recent statements from Ilya Sutskever, co-founder of OpenAI and Safe Superintelligence (SSI), who acknowledged that results from traditional AI scaling approaches have plateaued.
<a href="https://www.benzinga.com/tech/24/11/41932289/ai-capabilities-plateauing-say-andreessen-horowitz-founders-echoing-concerns-of-openai-co-founder-ilya-sutskever">Read the full article here.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/social-media/24/11/42022443/ibm-disney-and-other-large-advertisers-return-to-elon-musks-x-after-a-year-long-boycott-we-super-appreciate">IBM, Disney And Other Large Advertisers Return To Elon Musk&#8217;s X After A Year-Long Boycott</a></li>
</ul>
Photo courtesy: Shutterstock
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/Rounak-Jain" target="_blank" rel="noreferrer noopener">Rounak Jain</a>

AAPL

HNHPF

PGTRF

QUCCF

SFTBF

Nvidia, Apple Suppliers Prepare For Policy Shifts, Japan's AI Leap, And AMD's Workforce Cut: This Week In AI

These ten large-cap stocks were the best performers in the last week. Are they in your portfolio?
<ol>
<li>MicroStrategy Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) stock gained 25.97% last week amid the sharp rise in Bitcoin&#8217;s (CRYPTO: BTC/USD) price.</li>
<li>Shopify Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NYSE">SHOP</a>) shares escalated 24.53% after the company reported better-than-expected&nbsp;third-quarter results and several analysts revised <a href="https://www.benzinga.com//node/41950175" target="_blank" rel="noreferrer noopener">their price targets on the stock</a>.</li>
<li>Affirm Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>) gained 20.80% last week. Wells Fargo maintained an Overweight rating on the stock and raised its <a href="https://www.benzinga.com/quote/afrm/analyst-ratings" target="_blank" rel="noreferrer noopener">price forecast from $52 to $55</a>.</li>
<li>Walt Disney Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) stock upped 16.22% after announcing <a href="https://www.benzinga.com//node/41971559" target="_blank" rel="noreferrer noopener">fourth-quarter results</a>. Analysts raised the <a href="https://www.benzinga.com/quote/dis/analyst-ratings" target="_blank" rel="noreferrer noopener">price forecast on the stock</a>.</li>
<li>Spotify Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>) stock upped 14.39% after the company reported better-than-expected&nbsp;third-quarter&nbsp;earnings and <a href="https://www.benzinga.com//node/41950852" target="_blank" rel="noreferrer noopener">analysts boosted price targets.</a></li>
<li>Jack Dorsey&#8217;s Block, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQ#NYSE">SQ</a>) stock increased by 13.06%. Several analysts raised their <a href="https://www.benzinga.com/quote/sq/analyst-ratings" target="_blank" rel="noreferrer noopener">price forecasts</a> on the stock.</li>
<li>Coinbase Global Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) shares gained 12.97% last week. The company recently announced it acquired on-chain payments platform Utopia Labs. A sharp rise in Bitcoin price also played a part.</li>
<li>Palantir Technologies Inc.&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) stock upped 12.64%. The company announced it renewed its multi-year enterprise agreement with Rio Tinto for an additional four years of access to its AI platform. It also plans to transfer its stock <a href="https://www.benzinga.com//node/42010539" target="_blank" rel="noreferrer noopener">exchange listing to the Nasdaq</a>.</li>
<li>Grab Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRAB#NASDAQ">GRAB</a>) shares increased 11.82% &nbsp;after the company reported third-quarter&nbsp;results and raised its FY25 revenue<a href="https://www.benzinga.com//node/41889889" target="_blank" rel="noreferrer noopener"> guidance&nbsp;above estimates</a>.</li>
<li>NetEase, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTES#NASDAQ">NTES</a>) shares rose 11.37% after the company reported <a href="https://www.benzinga.com//node/41964319" target="_blank" rel="noreferrer noopener">third-quarter&nbsp;financial results</a>.</li>
</ol>
Photo by Useacoin on Shutterstock

AFRM

COIN

GRAB

MSTR

NTES

PLTR

SHOP

SPOT

Shopify, Disney And Coinbase Were Among Top 10 Large Cap Gainers Last Week (November 11-15): Are The Others In Your Portfolio?

The weekend was a whirlwind of political and business news. Former New Jersey Governor Chris Christie shared his views on the future of cannabis and cryptocurrency regulation, Senator Elizabeth Warren accused President-elect Donald Trump and his transition team of crossing legal boundaries and Trump announced his plans to appoint Elon Musk and Vivek Ramaswamy to lead a new government efficiency department, among major headlines. 
Christie&#8217;s Cannabis and Crypto Predictions: In an exclusive conversation with Benzinga Cannabis, Chris Christie, former New Jersey governor, discussed his perspectives on the future of cannabis and cryptocurrency regulation. He believes that under Trump&#8217;s leadership, both industries are set to experience significant changes. <a href="https://www.benzinga.com/markets/cannabis/24/11/41910180/exclusive-chris-christie-says-trump-will-remove-federal-restrictions-on-marijuana-find-sweet-spot-for-crypto-regulation">Read the full article here.</a>
Warren&#8217;s Legal Accusations: Massachusetts Senator Elizabeth Warren accused Donald Trump and his transition team of breaking the law. She stated that incoming presidents are required to prevent conflicts of interest and sign an ethics agreement, which Trump has yet to do. <a href="https://www.benzinga.com/24/11/41890244/elizabeth-warren-says-trump-and-his-transition-team-are-already-crossing-legal-boundaries-i-would-know-because-i-wrote-the-law">Read the full article here.</a>
Musk and Ramaswamy&#8217;s New Roles: President-elect Donald Trump said that he plans to appoint Tesla Inc CEO Elon Musk and former presidential candidate Vivek Ramaswamy to lead a new Department of Government Efficiency (DOGE). The department aims to restructure federal agencies and reduce government spending. <a href="https://www.benzinga.com/news/global/24/11/41927289/trump-appoints-elon-musk-and-vivek-ramaswamy-to-lead-doge-targeting-bureaucracy-and-65-trillion-federal-spending-we-will-not-go-gently">Read the full article here.</a>
DoorDash Wage Claims: Former DoorDash delivery workers claim they haven&#8217;t been paid thousands of dollars in wages from past years. They are seeking protection from deportation after Donald Trump&#8217;s recent win in the 2024 election. <a href="https://www.benzinga.com/news/legal/24/11/41996464/doordash-workers-claim-unpaid-wages-seek-protection-from-deportation-were-not-able-to-pay-the-rent">Read the full article here.</a>
Pentagon Overhaul Plans: President-elect Donald Trump&#8217;s transition team is reportedly planning a major overhaul at the Pentagon, including dismissing certain military officers. The planning for these dismissals is still in its early stages following Trump's election victory. <a href="https://www.benzinga.com/news/24/11/41963694/amid-appointment-of-elon-musk-vivek-ramswamy-team-trump-now-reportedly-planning-to-overhaul-military-posts">Read the full article here.</a>
Read Next: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41963342/elizabeth-warrens-sarcastic-take-on-doges-split-leadership-gets-slammed-by-elon-musk-unlike-you-neither-of-us-are-being-paid?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Elizabeth Warren&#8217;s Sarcastic Take On DOGE&#8217;s Split Leadership Gets Slammed By Elon Musk: &#8216;Unlike You, Neither Of Us Are Being Paid&#8217;</a>
Image via Flickr

Christie On Trump's Cannabis Plans, Elon Musk's New Role In Trump Team, Pentagon Overhaul Plans And More: This Week In Politics

In a departure from her family&#8217;s sports-oriented legacy, Taahirah O&#8217;Neal, the eldest daughter of basketball legend Shaquille O&#8217;Neal, has chosen to pursue a different career path and lifestyle.
What Happened: Taahirah O&#8217;Neal has not shown any interest in sports, unlike her siblings Shareef, Shaqir, Me&#8217;arah, and Amirah, who have all followed their father&#8217;s path into basketball. Taahirah has instead chosen a different path.
Earlier this year, Taahirah relocated to Georgia from Texas, where she had been employed as a communications associate analyst for PepsiCo. 
During a recent conversation with her cousin Marcus, she expressed her disinterest in sports, responding to his enthusiasm about a basketball event with indifference.
As reported <a href="https://www.essentiallysports.com/nba-legends-basketball-news-shaquille-oneals-daughter-with-arnetta-yardbourgh-defies-family-interests-with-truth-about-dads-profession/">by</a> Essentiallysports, Taahirah&#8217;s primary passion lies in nature and running a farm in Georgia, a passion she frequently shares on her Instagram posts.
Also Read: <a href="https://www.benzinga.com/general/sports/24/11/41866639/shaq-buys-out-delivery-teams-van-and-car-leaving-them-to-catch-an-uber">Shaq Buys Out Delivery Team&#8217;s Van and Car, Leaving Them To Catch An Uber</a>
She has also made it clear that she has no intention of dating athletes, stating, &#8220;No offense to athletes but I was raised by, raised with athletes. It's a no go for me.&#8221;
Earlier this year, during a podcast, she stated, as quoted by the sports outlet, "I have like the utmost respect for athletes. where I am in my life especially growing up the way that I did I don't want that for myself. I need your time. I really don't want to go toe-to-toe with someone's schedule."&nbsp;
Taahirah, a 2019 graduate of Oglethorpe University, has always maintained a strong bond with her mother, Arnetta Yardbourgh, despite her parents&#8217; separation. 
Her father, Shaquille O&#8217;Neal, has also expressed pride in her independence and ambitions.
Why It Matters: Taahirah&#8217;s decision to break away from her family&#8217;s sports legacy is a testament to her individuality and independence. 
Her choice of a different career path, her passion for nature and farming, and her decision not to date athletes, all highlight her determination to forge her own path. 
This story serves as a reminder that even in families with a strong legacy in a particular field, individual members can and do choose their own unique paths.
Read Next
<a href="https://www.benzinga.com/news/24/09/40764081/nba-star-chris-paul-says-to-prioritize-family-you-really-dont-realize-what-you-have-until-its-gone" target="_blank" rel="noreferrer noopener">NBA Star Chris Paul Says To Prioritize Family: ‘You Really Don't Realize What You Have Until It's Gone'</a>
This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.

Sports

NBA Legend Shaq's Daughter Breaks Silence On Dad's Career, Defying Family Expectations: 'It's A No Go For Me'

A Goldman Sachs economist has suggested that the US economy could experience accelerated growth with increased use of GLP-1 weight-loss drugs like Ozempic.
What Happened: Jan Hatzius, chief economist at Goldman Sachs, has said that US GDP could potentially grow an additional 1% if 60 million Americans were to use GLP-1 drugs by 2028.
Hatzius pointed out that health-related issues such as obesity often hinder people from participating in the labor force, thereby stunting economic growth, <a href="https://www.businessinsider.com/us-economy-faster-growth-ozempic-glp-1-weight-loss-drugs-2024-2">reports</a> Business Insider.
He further highlighted that healthcare innovation could significantly reduce the economic costs associated with poor health.
&#8220;Combining current losses in hours worked and labor force participation from sickness and disability, early deaths, and informal caregiving, we estimate that GDP would potentially be over 10% higher if poor health outcomes did not limit labor supply in the US,&#8221; the outlet quoted Hatzius saying.
GLP-1 drugs, including Ozempic and Mounjaro, are manufactured by Novo Nordisk and Eli Lilly and Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) respectively. These drugs have proven effective in treating type 2 diabetes and obesity, leading to a surge in sales.
Also Read: <a href="https://www.benzinga.com/markets/equities/24/07/39680165/eli-lillys-mounjaro-outpaces-novo-nordisks-ozempic-in-weight-loss-effectiveness-study-shows">Eli Lilly&#8217;s Mounjaro Outpaces Novo Nordisk&#8217;s Ozempic In Weight Loss Effectiveness, Study Shows</a>
Given the U.S. obesity rate of approximately 40%, tens of millions of Americans could be prescribed GLP-1 drugs in the upcoming years. Hatzius believes that this could lead to substantial economic benefits, including increased productivity.
&#8220;The main reason we see meaningful upside from healthcare innovation is that poor health imposes significant economic costs. There are several channels through which poor health weighs on economic activity that could diminish if health outcomes improve,&#8221; Hatzius said.
&#8220;These estimates therefore suggest that obesity-related health complications subtract over 3% from per-capita output, implying an over 1% hit to total output when combined with the over 40% incidence of obesity in the US population,&#8221; he added.
Why It Matters: The increased use of GLP-1 drugs could not only address the health crisis related to obesity but also stimulate economic growth. 
With the U.S. grappling with high obesity rates, the potential for these drugs to improve health outcomes and boost labor force participation could have far-reaching implications for the economy. 
The surge in sales of these drugs also indicates a growing market, which could further contribute to economic growth.
Read Next
<a href="https://www.benzinga.com/general/biotech/24/11/41706292/as-race-to-best-miracle-obesity-drug-heats-up-ozempic-maker-novo-nordisk-tests-new-hybrid-drug-th">As Race To Best &#8216;Miracle&#8217; Obesity Drug Heats Up, Ozempic Maker Novo Nordisk Tests New Hybrid Drug That Can Reduce Weight Up To 25%</a>
This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Image: Shutterstock

Health Care

Goldman Sachs Economist: Weight-Loss Drugs Could Be Key To US Economic Growth

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Every investment category must answer the big question, why? For undervalued <a href="https://investorplace.com/industries/healthcare/biotech/">biotech stocks</a>, it comes down to advantaging a supremely relevant sector without paying full price.



Of course, the broader healthcare ecosystem offers a compelling narrative for market participants. As the Covid-19 pandemic demonstrated, no matter how advanced we become as a society, a microscopic virus can impose devastation. In order to protect individuals and communities at large, enterprises need a way to address diseases: infectious, chronic, whatever the case may be.



Further, undervalued biotech stocks enjoy a massive canvas for value expansion. According to Grand View Research, the global biotech arena <a href="https://www.grandviewresearch.com/industry-analysis/biotechnology-market">could be worth $3.88 trillion by 2030</a>. If so, that would imply a compound annual growth rate (CAGR) of 13.96% from 2023.



Plus, let&rsquo;s consider the unfortunate rise of cancer and other serious diseases. It wouldn&rsquo;t be surprising in the least if the aforementioned projection was conservative. With that in mind, below are undervalued biotech stocks to consider.



<h2>Procaps (PROC)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/05/biotech_bigpharma1600-300x169.png" alt="Light blue pills on white background. Pharmaceutical industry, medical treatment, presciption drugs concept. Digital 3D render., biotech stocks, big pharma. EVAX stock"><div>Source: Hernan E. Schmidt / Shutterstock.com</div></div>Based in Luxembourg, Procaps (NASDAQ:<a href="https://investorplace.com/stock-quotes/proc-stock-quote/">PROC</a>) develops, produces and markets pharmaceutical solutions. It formulates and manufactures <a href="https://finance.yahoo.com/quote/PROC/profile/">branded prescription drugs</a> in multiple therapeutic areas, such as feminine care, pain relief, skin care and digestive health, among other needs. It should be noted that since the start of the year, PROC lost more than 41% of its equity value. Still, for those who want to speculate on undervalued biotech stocks, PROC could be a high-risk, high-reward idea. Right now, shares trade hands at 0.65X trailing-year sales. For the drug manufacturing sector, the median <a href="https://www.gurufocus.com/stock/PROC/summary?search=proc">value stands at 2.08X</a>. More importantly, the market has already demonstrated that it will accept a higher valuation for the business.



Over the last four quarters, PROC stock traded at an <a href="https://finance.yahoo.com/quote/PROC/key-statistics/">average sales multiple of around 0.94X</a>. Theoretically, then, the biotech room can potentially grow into its prior valuation. Over the longer term, that&rsquo;s what Wall Street experts are anticipating.



For fiscal 2024, sales could rise 3.5% to reach $424.15 million. In the following year, the top line could bump up to $460.35 million.



<h2>MiMedx (MDXG)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/02/medical-biotech-stocks1600-300x169.png" alt="Healthcare business graph data and growth, Medical examination and doctor analyzing medical report network connection on tablet screen. VANI stock"><div>Source: PopTika / Shutterstock.com</div></div>Headquartered in Marietta, Georgia, MiMedx (NASDAQ:<a href="https://investorplace.com/stock-quotes/mdxg-stock-quote/">MDXG</a>) develops and <a href="https://finance.yahoo.com/quote/MDXG/profile/">distributes placental tissue allografts</a> for various sectors of the healthcare ecosystem. Specifically, MiMedx processes human placental tissues through its proprietary process to produce allografts. This methodology carries the advantage of retaining the tissue&rsquo;s inherent biological properties and regulatory proteins.



MDXG stock is a speculative entity, losing about 12% of market value since the start of the year. Nevertheless, the red ink may be creating a discounted opportunity. Presently, MDXG trades at 3.21X trailing-year revenue. However, during the first quarter of this year, the multiple did pop up to 3.5X. On the surface, that might not seem like much of a discount.



Still, it&rsquo;s important to consider what experts are anticipating moving forward. For fiscal 2024, they&rsquo;re targeting revenue of $361.49 million. If so, that would represent a 12.4% lift from last year&rsquo;s print of $321.48 million. And fiscal 2025 could see the top line move up to $406.17 million, another 12.4% leap.



To be sure, MiMedx represents a higher-risk idea. Still, it qualifies as one of the undervalued biotech stocks to consider.



<h2>MEI Pharma (MEIP)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600-300x169.png" alt="Biotechnology stocks, biomedical stocks"><div>Source: aslysun / Shutterstock.com</div></div>Operating out of San Diego, California, MEI Pharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/meip-stock-quote/">MEIP</a>) is a small outfit, featuring only 46 full-time employees. It&rsquo;s a clinical-stage pharmaceutical firm, focusing on the development and commercialization of various therapies for the treatment of cancer. The company has developed a <a href="https://finance.yahoo.com/quote/MEIP/profile/">therapeutic called Zandelisib</a>, which addresses relapsed and refractory follicular lymphoma.



Another high-risk entity, MEIP stock dropped almost 52% of equity value since the start of the year. However, it also appears that the volatility has slowed down. In the trailing month, shares only slipped about 0.3%. Further, the sales multiple seems attractive at only 0.29X. In the past year (Q1 2023 to Q1 2024), the multiple averaged about 0.59X.



It&rsquo;s also worth pointing out that MEIP trades at a trailing-year earnings multiple of 0.74X. Moving forward to the end of the year, analysts anticipate earnings per share to reach $3.62. On the top line, sales may enjoy a 33.8% lift to $65.3 million. Assuming these projections hold true, MEIP could easily grow into its valuation on earnings and sales. Thus, it&rsquo;s one of the undervalued biotech stocks to consider.



<h2>Incyte (INCY)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/09/incy-stock-1-300x169.jpg" alt="incy stock"><div>Source: Eyesonmilan / Shutterstock.com</div></div>Based in Wilmington, Delaware, Incyte (NASDAQ:<a href="https://investorplace.com/stock-quotes/incy-stock-quote/">INCY</a>) is a biopharmaceutical firm engaged in the discovery, development and commercialization of therapeutics for hematology and oncology. It also specializes in conditions revolving around inflammation and autoimmunity. It&rsquo;s a sizable player compared to the speculative plays among undervalued biotech stocks, with more than 2,500 full-time employees.



Financially, Incyte is a solid entity. During the trailing 12 months (TTM), Incyte posted net income of $745.44 million or earnings of $3.30 per share. Revenue reached $3.77 billion. Still, INCY stock trades at 3.64X trailing-year sales. Over the past year, this stat averaged 3.98X.



On the bottom line, the market prices INCY at 13.16X forward earnings. In the past year, the average multiple clocked in at 14.61X. But here&rsquo;s the kicker: analysts anticipate sizable expansion of the top and bottom lines.



Fiscal 2024 could see EPS at $4.30, up 22.16% over the prior year. Revenue could jump 10.6% to reach $4.09 billion. Therefore, it&rsquo;s one of the undervalued biotech stocks to put on your radar.



<h2>United Therapeutics (UTHR)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/05/uthr_unitedtheraputics1600-300x169.png" alt="In this photo illustration United Therapeutics Corporation (UTHR) logo is seen on a mobile phone screen."><div>Source: viewimage / Shutterstock.com</div></div>Headquartered in Silver Spring, Maryland, United Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/uthr-stock-quote/">UTHR</a>) engages in the development and commercialization of products to address unmet medical needs, particularly for patients suffering from chronic and life-threatening diseases. It offers multiple products, including <a href="https://finance.yahoo.com/quote/UTHR/profile/">Tyvaso DPI</a>, which is an inhaled dry powder for the treatment of pulmonary arterial hypertension (PAH).



Financially, United represents another solid idea among undervalued biotech stocks. Net income during the TTM period landed at $1.05 billion or $21.13 per share. Revenue in the cycle reached $2.5 billion. Currently, the market prices UTHR stock at 6.34X trailing-year sales, which admittedly is at a premium.



However, analysts believe that in fiscal 2024, sales could hit $2.74 billion, up 17.8% from the prior year&rsquo;s tally of $2.33 billion. Assuming a shares outstanding count of $44.37 million, UTHR would trade at a projected sales multiple of around 5.16X.



Now, the average multiple over the past year came in at 5.24X. So, ever so slightly, UTHR ranks among the undervalued biotech stocks. Plus, the benefit here is that you&rsquo;re dealing with a profitable and growing enterprise.



<h2>Harmony Biosciences (HRMY)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/12/shutterstock_1726134715-300x169.png" alt="Biochemical/biotech research scientist team working with microscope"><div>Source: Mongkolchon Akesin / Shutterstock.com</div></div>Operating out of Plymouth Meeting, Pennsylvania, Harmony Biosciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/hrmy-stock-quote/">HRMY</a>) is a commercial-stage pharmaceutical firm focusing on the development and commercialization of therapies for patients with rare and neurological diseases. Its <a href="https://finance.yahoo.com/quote/HRMY/profile/">main product is WAKIX</a>, a molecule with a novel mechanism for the treatment of excessive daytime sleepiness in adults with narcolepsy.



For a relatively small enterprise, Harmony offers robust financials. During the TTM period, the company posted net income of $137.7 million or earnings of $2.32 per share. On the top line, sales in the period reached $617.51 million. In the most recent quarter, HRMY&rsquo;s quarterly sales growth rate (year-over-year0 landed at 29.8%.



Right now, HRMY stock trades at 2.91X trailing-year sales. In the past one-year period, the average multiple stood at 4.05X. Even better, covering experts see Harmony&rsquo;s revenue rising by 22% to $710.15 million. Further, the high-side target runs up to $718.4 million.



For fiscal 2025, the consensus view calls for $836.82 million, up 17.8%. As a bonus, EPS in fiscal 2025 may also soar nearly 75% to $3.90. It&rsquo;s one of the undervalued biotech stocks to consider.



<h2>ScyNexis (SCYX)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/10/droplet-test-tube-biotech-1600-3-300x169.jpg" alt="Photo of test tubes and droplet with purple and reddish-orange sunset visual effect, representing biotech"><div>Source: shutterstock.com/Romix Image</div></div>Based in Jersey City, New Jersey, ScyNexis (NASDAQ:<a href="https://investorplace.com/stock-quotes/scyx-stock-quote/">SCYX</a>) falls under the drug manufacturing ecosystem. <a href="https://finance.yahoo.com/quote/SCYX/profile/">Per its public profile</a>, ScyNexis develops medicines to overcome and prevent difficult-to-treat and drug-resistant infections. One of its main products is Brexafemme for the treatment of patients with certain feminine conditions. It also offers other treatments for important but sensitive conditions.



SCYX stock is a difficult entity to bet on. Since the start of the year, it lost about 10% of market value. Over the past 52 weeks, it&rsquo;s down about 34%. At the same time, it also offers some financial substance. During the TTM period, the company posted net income of $101.33 million or $2.11 per share. Revenue landed at $140.38 million. Its latest quarterly sales growth rate clocked in at 21.5%.



That said, analysts anticipate an 82% erosion in the top line for fiscal 2024 to $25.1 million. Last year, the company generated sales of $140.14 million. Obviously, that&rsquo;s not a great look, leading to a trailing-year sales multiple of 0.69X. In the past year, this stat averaged 10.41X.



However, in fiscal 2025, a gradual recovery trek may materialize, resulting in sales of $44.07 million. Further, the high-side target calls for $116.25 million, making SCYX potentially one of the undervalued biotech stocks.



On the date of publication, Josh Enomoto did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<div>A former senior business analyst for Sony Electronics, Josh Enomoto has helped broker major contracts with Fortune Global 500 companies. Over the past several years, he has delivered unique, critical insights for the investment markets, as well as various other industries including legal, construction management, and healthcare. Tweet him at @EnomotoMedia.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/07/7-undervalued-biotech-stocks-to-buy-for-big-time-returns/">7 Undervalued Biotech Stocks to Buy for Big-Time Returns</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

7 Undervalued Biotech Stocks to Buy for Big-Time Returns

Procaps Group (PROC) has released an update. Procaps Group is undergoing an internal investigation regarding historical accounting treatments and f...

Procaps Group Faces Audit Report Withdrawal Amid Investigation

Procaps Group (PROC) has released an update. Procaps Group, S.A. has entered into forbearance agreements with its creditors concerning approximatel...

Procaps Group Negotiates Forbearance on Debt

Procaps Group (PROC) has released an update. Procaps Group CEO José Antonio Vieira has reiterated his commitment to guiding the company to growth, ...

Procaps Group Navigates Challenges, Outperforms Market

Procaps Group (PROC) has released an update. Procaps Group has announced a significant milestone in its financial restructuring, having secured for...

Procaps Group Advances Strategic Financial Restructuring

Procaps Group (PROC) has released an update. Procaps Group, S.A. has announced the immediate resignation of Mr. Ruben Minski from its Board of Dire...

Procaps Group Announces Board Resignation

Procaps Group (PROC) has released an update. Procaps Group, S.A. has announced its intention to restate financial statements due to errors and miss...

Procaps Group Announces Financial Restatement Plans

Procaps Group (PROC) has released an update. Procaps Group is taking strategic steps to navigate financial challenges, including appointing a new b...

Procaps Group's Strategic Moves for Financial Stability

Procaps Group (PROC) has released an update. Procaps Group faces potential suspension and delisting from Nasdaq due to delays in filing its 2023 fi...

Procaps Group Seeks Nasdaq Resolution Amid Filing Delays

Procaps Group (PROC) announced that, on November 13, the company received formal notice from the Listing Qualifications Department of The Nasdaq St...

Comments

Procaps Gr

Procaps Gr (PROC) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO